Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review

被引:17
作者
Vancsa, Szilard [1 ,2 ]
Hegyi, Peter Jeno [1 ]
Zadori, Noemi [1 ,2 ]
Szako, Lajos [1 ,2 ]
Vorhendi, Nora [1 ,2 ]
Ocskay, Klementina [1 ,2 ]
Foldi, Maria [1 ,2 ,3 ]
Dembrovszky, Fanni [1 ,2 ]
Domotor, Zsuzsa Reka [4 ]
Janosi, Kristof [5 ]
Rakonczay, Zoltan, Jr. [6 ]
Hartmann, Petra [7 ]
Horvath, Tamara [7 ]
Eross, Balint [1 ]
Kiss, Szabolcs [1 ,2 ,3 ]
Szakacs, Zsolt [1 ,2 ]
Nemeth, David [1 ]
Hegyi, Peter [1 ,2 ]
Par, Gabriella [8 ]
机构
[1] Univ Pecs, Sch Med, Inst Translat Med, Pecs, Hungary
[2] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary
[3] Univ Szeged, Doctoral Sch Clin Med, Szeged, Hungary
[4] George Emil Palade Univ Med Pharm Sci & Technol T, Fac Med, Targu Mures, Romania
[5] Univ Pecs, Sch Med, Inst Heart, Pecs, Hungary
[6] Univ Szeged, Dept Pathophysiol, Szeged, Hungary
[7] Univ Szeged, Inst Surg Res, Szeged, Hungary
[8] Univ Pecs, Div Gastroenterol, Dept Med 1, Sch Med, Pecs, Hungary
关键词
SARS— CoV-2; COVID-19; prognosis; hepatology; pandemic (COVID-19); CLINICAL CHARACTERISTICS; CIRRHOSIS; BIAS;
D O I
10.3389/fmed.2020.572115
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We aimed to perform a systematic search and meta-analysis to evaluate the prognostic value of on-admission liver function tests and pre-existing liver diseases on the clinical course of coronavirus disease 2019 (COVID-19). Methods: The study was registered on PROSPERO (CRD42020182902). We searched five databases between 01/01/2020 and 04/23/2020. Studies that reported on liver-related comorbidities and/or laboratory parameters in patients with COVID-19 were included. The main outcomes were COVID-19 severity, intensive care unit (ICU) admission, and in-hospital mortality. Analysis of predictive models hierarchical summary receiver-operating characteristic (HSROC) was conducted with a 95% confidence interval (CI). Results: Fifty studies were included in the meta-analysis. High specificity was reached by acute liver failure associated by COVID-19 (0.94, 95% CI: 0.71-0.99) and platelet count (0.94, 95% CI: 0.71-0.99) in the case of mortality; chronic liver disease (CLD) (0.98, 95% CI: 0.96-0.99) and platelet count (0.82, 95% CI: 0.72-0.89) in the case of ICU requirement; and CLD (0.97, 95% CI: 0.95-0.98), chronic hepatitis B infection (0.97, 95% CI: 0.95-0.98), platelet count (0.86, 95% CI: 0.77-0.91), and alanine aminotransferase (ALT) (0.80, 95% CI: 0.66-0.89) and aspartate aminotransferase (AST) (0.84, 95% CI: 0.77-0.88) activities considering severe COVID-19. High sensitivity was found in the case of C-reactive protein (CRP) for ICU requirement (0.92, 95% CI: 0.80-0.97) and severe COVID-19 (0.91, 95% CI: 0.82-0.96). Conclusion: On-admission platelet count, ALT and AST activities, CRP concentration, and the presence of acute and CLDs predicted the severe course of COVID-19. To highlight, pre-existing liver diseases or acute liver injury associated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection plays an important role in the prediction of mortality.
引用
收藏
页数:11
相关论文
共 80 条
  • [1] Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
    Albillos, Agustin
    Lario, Margaret
    Alvarez-Mon, Melchor
    [J]. JOURNAL OF HEPATOLOGY, 2014, 61 (06) : 1385 - 1396
  • [2] [Anonymous], 2020, CORONAVIRUS DIS COVI
  • [3] Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
    Arentz, Matt
    Yim, Eric
    Klaff, Lindy
    Lokhandwala, Sharukh
    Riedo, Francis X.
    Chong, Maria
    Lee, Melissa
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16): : 1612 - 1614
  • [4] COVID-19: Abnormal liver function tests
    Cai, Qingxian
    Huang, Deliang
    Yu, Hong
    Zhu, Zhibin
    Xia, Zhang
    Su, Yinan
    Li, Zhiwei
    Zhou, Guangde
    Gou, Jizhou
    Qu, Jiuxin
    Sun, Yan
    Liu, Yingxia
    He, Qing
    Chen, Jun
    Liu, Lei
    Xu, Lin
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (03) : 566 - 574
  • [5] COVID-19 in a designated infectious diseases hospital outside Hubei Province, China
    Cai, Qingxian
    Huang, Deliang
    Ou, Pengcheng
    Yu, Hong
    Zhu, Zhibin
    Xia, Zhang
    Su, Yinan
    Ma, Zhenghua
    Zhang, Yiming
    Li, Zhiwei
    He, Qing
    Liu, Lei
    Fu, Yang
    Chen, Jun
    [J]. ALLERGY, 2020, 75 (07) : 1742 - 1752
  • [6] Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China
    Cao, Jianlei
    Tu, Wen-Jun
    Cheng, Wenlin
    Yu, Lei
    Liu, Ya-Kun
    Hu, Xiaoyong
    Liu, Qiang
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) : 748 - 755
  • [7] Chai X, 2020, bioRxiv, DOI [10.1101/2020.02.03.931766, 10.1101/2020.02.03.931766v1, DOI 10.1101/2020.02.03.931766]
  • [8] Clinical and immunological features of severe and moderate coronavirus disease 2019
    Chen, Guang
    Wu, Di
    Guo, Wei
    Cao, Yong
    Huang, Da
    Wang, Hongwu
    Wang, Tao
    Zhang, Xiaoyun
    Chen, Huilong
    Yu, Haijing
    Zhang, Xiaoping
    Zhang, Minxia
    Wu, Shiji
    Song, Jianxin
    Chen, Tao
    Han, Meifang
    Li, Shusheng
    Luo, Xiaoping
    Zhao, Jianping
    Ning, Qin
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05) : 2620 - 2629
  • [9] Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China
    Chen, Ruchong
    Liang, Wenhua
    Jiang, Mei
    Guan, Weijie
    Zhan, Chen
    Wang, Tao
    Tang, Chunli
    Sang, Ling
    Liu, Jiaxing
    Ni, Zhengyi
    Hu, Yu
    Liu, Lei
    Shan, Hong
    Lei, Chunliang
    Peng, Yixiang
    Wei, Li
    Liu, Yong
    Hu, Yahua
    Peng, Peng
    Wang, Jianming
    Liu, Jiyang
    Chen, Zhong
    Li, Gang
    Zheng, Zhijian
    Qiu, Shaoqin
    Luo, Jie
    Ye, Changjiang
    Zhu, Shaoyong
    Liu, Xiaoqing
    Chang, Linling
    Ye, Feng
    Zheng, Jinping
    Zhang, Nuofu
    Li, Yimin
    He, Jianxing
    Li, Shiyue
    Zhong, Nanshan
    [J]. CHEST, 2020, 158 (01) : 97 - 105
  • [10] Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]